A landmark step towards patient safety and product authenticity! Effective 9th October 2026, 2D Barcodes and Serialization are now mandatory for all pharmaceutical products manufactured or imported into Pakistan.
This progressive regulatory initiative:
🛡️ Curbs Counterfeit Medicines: Safeguards public health against substandard and fake drugs.
🔍 Enables Traceability & Verification: Ensures full end-to-end supply chain tracking.
📦 Improves Supply Chain Transparency: Establishes higher visibility from factory to patient.
🤝 Builds a Safer Healthcare Future: Guarantees access to safe, genuine, and high-quality medicines for every patient.
PPMA supports measures that enhance patient safety and quality standards across the national pharmaceutical sector.
